April 11, 2024 – Page 6 – Goldea Capital

Following Share Stake Sale to Executive Chairman Daniel McClory, Alessandro Aleotti to Focus on AleottiLab

Written by Customer Service on April 11, 2024. Posted in Public Companies.

Control Block Sale of Brera FC Founder’s Position Results in New Majority Shareholder DUBLIN, Ireland and MILAN, Italy, April 11, 2024 (GLOBE NEWSWIRE) — Brera Holdings PLC (“Brera Holdings”, “Brera” or the “Company”) (Nasdaq: BREA), one of the world’s first publicly-listed multi-club ownership (“MCO”) companies for football (American soccer), announces that Alessandro Aleotti has resigned from all his positions with the Company effective as of April 4, 2024, to pursue philanthropic endeavors. “I am proud to have given life to a project that has now landed on the international sporting and financial stage,” Aleotti declared. “I am now eager to pivot back to my greatest passions: pioneering ideas and developing experimental initiatives under the umbrella of AleottiLab. This organization will dedicate its efforts towards projects...

MariMed Closes Acquisition of Thrive Dispensary in Casey, The Company’s Fifth Illinois Dispensary

Written by Customer Service on April 11, 2024. Posted in Mergers And Acquisitions.

NORWOOD, Mass., April 11, 2024 (GLOBE NEWSWIRE) — MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced the closing of its acquisition of Allgreens Dispensary, LLC on April 9, 2024. The approval of the license transfer by the Illinois Department of Financial & Professional Regulation, and subsequent closing of the acquisition, allows MariMed to fully consolidate the financial results of the Company’s Thrive-branded dispensary in Casey, Illinois, which had previously been operated under a Managed Services Agreement. Thrive Casey is the only dispensary in Clark County, Illinois, 30 miles west of Terre Haute, Indiana. Thrive Casey is located at 912 N. State Highway 49, near the intersection of state Highway 49 and U.S. Interstate 70. The...

Constellation Brands Reports Fiscal Year and Fourth Quarter 2024 Financial Results and Fiscal Year 2025 Outlook

Written by Customer Service on April 11, 2024. Posted in Earnings Releases And Operating Results.

VICTOR, N.Y., April 11, 2024 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, reported today its fiscal year and fourth quarter 2024 financial results and fiscal year 2025 outlook. A conference call to discuss the financial results and outlook will be hosted by President and Chief Executive Officer, Bill Newlands, and Chief Financial Officer, Garth Hankinson, on Thursday, April 11, 2024 at 10:30 a.m. EDT. Visit ir.cbrands.com to locate information for joining the conference call, or a live, listen-only webcast of the conference call. ABOUT CONSTELLATION BRANDSConstellation Brands (NYSE: STZ) is a leading international producer and marketer of beer, wine, and spirits with operations in the U.S., Mexico, New Zealand, and Italy. Our mission is to build brands that people love because we...

Enliven Therapeutics Announces Positive Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia

Written by Customer Service on April 11, 2024. Posted in Public Companies.

Achieved initial cumulative MMR rate of 44% (7/16) by 12 weeks in response-evaluable patients, which compares favorably to precedent Phase 1 trials of approved BCR::ABL1 TKIs Achieved initial cumulative MMR rate of 44% (4/9) by 12 weeks in response-evaluable patients who were previously treated with asciminib ELVN-001 was well tolerated with no ≥ Grade 3 treatment-related non-hematologic toxicities reported Company to host virtual event with Key Opinion Leaders at 8:00 AM ET Today BOULDER, Colo., April 11, 2024 (GLOBE NEWSWIRE) — Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage precision oncology company focused on the discovery and development of next-generation small molecule kinase inhibitors, today announced positive proof of concept data from the Phase 1 clinical trial evaluating ELVN-001...

Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer

Written by Customer Service on April 11, 2024. Posted in Public Companies.

– Arvinas to receive a $150 million upfront payment for the license of ARV-766 and the sale of Arvinas’ preclinical AR-V7 program, with the potential under the License Agreement for up to $1.01 billion in development, regulatory, and commercial milestones, as well as tiered royalties – – Novartis to be responsible for worldwide clinical development and commercialization of ARV-766 – – Partnership expected to accelerate and broaden the development of ARV-766 as a potential first-in-class treatment option for patients with prostate cancer – NEW HAVEN, Conn., April 11, 2024 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced it has entered into an exclusive strategic license agreement with Novartis (NYSE: NVS)...

Fortrea Announces Date for First Quarter 2024 Financial Results and Conference Call

Written by Customer Service on April 11, 2024. Posted in Public Companies.

DURHAM, N.C., April 11, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024. Fortrea will host a conference call at 9:00 am ET that day to review its financial results and conduct a question-and-answer session. To participate in the earnings call, participants should register online at the Fortrea Investor Relations website. To avoid potential delays, please join at least 10 minutes prior to the start of the call. The conference call can also be accessed through the following earnings webcast link. A replay of the live conference call will be available shortly after the conclusion of the event and accessible on the events and presentations...

Tiziana Life Sciences Announces Platform Presentation of New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology

Written by Customer Service on April 11, 2024. Posted in Public Companies.

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough neuro-immunomodulation therapies, today announced an upcoming oral presentation, titled, “Treatment of PIRA with Nasal Foralumab Dampens Microglial Activation and Stabilizes Clinical Progression in Non-Active Secondary Progressive MS” that will be presented during the “Multiple Sclerosis: Therapeutics and Clinical Decision Making” session at the Annual Meeting of the American Academy of Neurology, to be held April 13-18, 2024 in Denver, Colorado. Presentation Information: Presenter: Tarun Singhal, M.B.B.S., M.D. (Associate Professor of Neurology, Harvard Medical School, and Associate Neurologist, Brigham and Women’s Hospital, a founding member of Mass General Brigham...

ConnectOne Bancorp, Inc. to Host 2024 First Quarter Results Conference Call on April 25, 2024

Written by Customer Service on April 11, 2024. Posted in Public Companies.

ENGLEWOOD CLIFFS, N.J., April 11, 2024 (GLOBE NEWSWIRE) — ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company of ConnectOne Bank (the “Bank”), today announced that it plans to release results for the first quarter ended March 31, 2024, before the market opens on Thursday, April 25, 2024. Management will also host a conference call and audio webcast at 10:00 a.m. ET on April 25, 2024, to review the Company’s financial performance and operating results. Chairman and Chief Executive Officer Frank Sorrentino III and Senior Executive Vice President and Chief Financial Officer William S. Burns will host the call. The conference call dial-in number is 1 (646) 307-1963, access code 6725677. Please dial in at least five minutes before the start of the call to register. An audio webcast of the conference...

Microbix Presenting at the 2024 Bloom Burton Conference

Written by Customer Service on April 11, 2024. Posted in Public Companies.

MISSISSAUGA, Ontario, April 11, 2024 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will be attending and presenting at the Bloom Burton & Co. Healthcare Investor Conference (the “Conference”) taking place at the Metro Toronto Convention Center, North Building, on April 16 and 17, 2024. The Conference provides an opportunity to connect with Canadian, U.S., and international investors who are interested in the latest developments in the Canadian healthcare and life sciences sector. Microbix’s CEO and President, Cameron Groome, will make an in-person group presentation to investors on Tuesday, April 16 at 10:30 AM Eastern Time. Senior management will also participate in multiple one-on-one meetings with investors at the Conference....

Company Provides Operational Update for Monterey County Oil Producing Assets

Written by Customer Service on April 11, 2024. Posted in Public Companies.

Combined Oil Production Stabilized at 75 Barrels Per Day Bakersfield, CA, April 11, 2024 (GLOBE NEWSWIRE) — Trio Petroleum Corp (NYSE American: “TPET”, “Trio” or the “Company”), a California-based oil and gas company, today provided an update on its oil producing assets in Monterey County, California, including at the Presidents Field (“Presidents”) of the South Salinas Project and at the McCool Ranch Field (“McCool Ranch”). “We are pleased to provide this operational update on our two oil producing assets in Monterey County,” commented Michael Peterson, CEO of Trio Petroleum. “The Company currently operates two highly promising, proven petroleum assets in Monterey County in the Presidents Field and the McCool Ranch, and we are very encouraged by our recent operational results at both fields.” “Bringing these wells back online...

Day: April 11, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice